The DOI matches its Crossref record; 706 of the 706 references it cites were found in a registry or an index.
The role of serotonin in drug use and addiction
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 706
Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist
Dawson, L. A., Nguyen, H. Q., & Li, P. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00967-x · Cited by 51
Saules, K. K., Schuh, L. M., Arfken, C. L., Reed, K., Kilbey, M. M., & Schuster, C. R. (2004) · American Journal on Addictions · doi:10.1080/10550490490512762 · Cited by 51
Rodd, Z. A., Bell, R. L., Oster, S. M., Toalston, J. E., Pommer, T. J., McBride, W. J., & Murphy, J. M. (2010) · Alcohol · doi:10.1016/j.alcohol.2010.01.002 · Cited by 51
Lee, C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00336-6 · Cited by 51
Overstreet, D. H., McArthur, R. A., Rezvani, A. H., & Post, C. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199711000-00015 · Cited by 51
Popova, N. K., Vishnivetskaya, G. B., Иванова, Е. А., Skrinskaya, J. A., & Seif, I. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00417-2 · Cited by 50
Ding, Z., Oster, S. M., Hall, S. R., Engleman, E. A., Hauser, S. R., McBride, W. J., & Rodd, Z. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2208-5 · Cited by 50
Dopaminergic mechanisms of reinstatement of MDMA‐seeking behaviour in rats
Schenk, S., Gittings, D., & Colussi‐Mas, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01193.x · Cited by 49
Serotonin depletion causes long-term reduction of exploration in the rat
Lipska, B. K., Jaskiw, G. E., Arya, A., & Weinberger, D. R. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90510-m · Cited by 49
Hynes, M. D., Lochner, M. A., Bemis, K. G., & Hymson, D. L. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90321-2 · Cited by 49
Effect of serotonin (5-HT) 1B receptor ligands on cocaine sensitization in rats
Przegaliński, E., Filip, M., Papla, I., & Siwanowicz, J. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200104000-00004 · Cited by 49
Sertraline delays relapse in recently abstinent cocaine‐dependent patients with depressive symptoms
Oliveto, A. H., Poling, J. C., Mancino, M. J., Williams, D. K., Thostenson, J., Pruzinsky, R., Gonsai, K., Sofuoglu, M., Gonzalez, G. M., Tripathi, S. P., et al. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03552.x · Cited by 48
David, V., Ségu, L., Buhot, M.-C., Ichaye, M., & Cazala, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1767-5 · Cited by 48
Müller, C. P., Silva, M. A. D. S., DePalma, G., Tomaz, C. A. B., Carey, R. J., & Huston, J. P. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00042-6 · Cited by 48
Self-citationCarey, R. J., DePalma, G., Damianopoulos, E. N., Hopkins, A., Shanahan, A., Müller, C. P., & Huston, J. P. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.091 · Cited by 48
Self-citationThe discriminative stimulus effects of methamphetamine in pigeons
Sasaki, J. E., Tatham, T. A., & Barrett, J. E. (1995) · Psychopharmacology · doi:10.1007/bf02311178 · Cited by 48
Systemic and local cocaine increase extracellular serotonin in the nucleus accumbens
Teneud, L., Baptista, T., Murzi, E., Hoebel, B. G., & Hernandez, L. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02087-x · Cited by 47
Colpaert, F. C., Deseure, K. R., Stinus, L., & Adriaensen, H. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095109 · Cited by 47
Murnane, K. S., Winschel, J., Schmidt, K. T., Stewart, L. M., Rose, S. J., Cheng, K., Rice, K. C., & Howell, L. L. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1437-13.2013 · Cited by 47
Differential role of serotonergic polymorphisms in alcohol and heroin dependence
Sáiz, P. A., García‐Portilla, M. P., Flórez, G., Arango, C., Corcoran, P. E., Morales, B., Bobes-Bascarán, T., Alvarez, C., Narciso, G. S., Carreño, E., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.016 · Cited by 47
Agatsuma, S., Lee, M.-S., Zhu, H., Chen, K., Shih, J. C., Seif, I., & Hiroi, N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl206 · Cited by 47
Pentkowski, N. S., Cheung, T. H. C., Toy, W. A., Adams, M. D., Neumaier, J. F., & Neisewander, J. L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.024 · Cited by 46
Lerer, E., Kanyas, K., Karni, O., Ebstein, R. P., & Lerer, B. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001855 · Cited by 46
Fluoxetine-induced attenuation of amphetamine self-administration in rats
Yu, D. S. L., Smith, F. L., Smith, D. G., & Lyness, W. H. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90337-1 · Cited by 46
Zaniewska, M., McCreary, A. C., Przegaliński, E., & Filip, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.067 · Cited by 46
Absence of Cocaine-induced Place Conditioning in Serotonin 1B Receptor Knock-out Mice
Belzung, C., Scearce-Levie, K. A., Barreau, S., & Hen, R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00238-0 · Cited by 46
Rasmussen, K., & Czachura, J. F. (1997) · Psychopharmacology · doi:10.1007/s002130050411 · Cited by 45
Müller, C. P., & Schumann, G. (2011) · Behavioral and Brain Sciences · doi:10.1017/s0140525x1100135x · Cited by 45
Self-citationHayes, D. J., Mosher, T. M., & Greenshaw, A. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.034 · Cited by 45
Gerra, G., Zaimovic, A., Garofano, L., Ciusa, F., Moi, G., Avanzini, P., Talarico, E., Gardini, F., Brambilla, F., Manfredini, M., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30388 · Cited by 45
Morrow, B. A., & Roth, R. H. (1996) · Synapse · Cited by 44
Zorick, T. S., Sugar, C. A., Hellemann, G., SHOPTAW, S. J., & London, E. D. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.04.015 · Cited by 44
Singh, V. P., Jain, S., & Kulkarni, S. (2003) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2003.25.4.769675 · Cited by 44
Avraham, Y., Ben‐Shushan, D., Breuer, A., Zolotarev, O., Okon, A., Fink, N., Katz, V., & Berry, E. M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.01.015 · Cited by 44
de Bruin, N. M. W. J., McCreary, A. C., van Loevezijn, A., Vries, T. J. D., Venhorst, J., Drimmelen, M. V., & Kruse, C. G. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.048 · Cited by 44
Effects of Chronic Buspirone Treatment on Cocaine Self-Administration
Mello, N. K., Fivel, P. A., Kohut, S. J., & Bergman, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.202 · Cited by 44
Nonkes, L. J. P., Maes, J. H. R., & Homberg, J. R. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00351.x · Cited by 43
Self-citationInfusion of Nicotine Into the LHA Enhances Dopamine And 5-HT Release and Suppresses Food Intake
Yang, Z.-J., Blaha, V., Meguid, M. M., Oler, A., & Miyata, G. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00111-2 · Cited by 43
Rasmussen, K., Kallman, M. J., & Helton, D. R. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199710)27:2<145::aid-syn5>3.0.co;2-e · Cited by 43
Gravius, A., Laszy, J., Pietraszek, M., Sághy, K., Nagel, J., Chambon, C., Wegener, N., Valastro, B., Danysz, W., & Gyertyán, I. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328343d804 · Cited by 43
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
Levin, E. D., Slade, S. K., Johnson, M., Petro, A. E., Horton, K., Williams, P., Rezvani, A. H., & Rose, J. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.016 · Cited by 43
Cocaine increases 5-HT1B mRNA in rat nucleus accumbens shell neurons
Hoplight, B. J., Vincow, E. S., & Neumaier, J. F. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.013 · Cited by 43
Ball, K. T., & Rebec, G. V. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0038-z · Cited by 43
Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine
Wooters, T. E., Bevins, R. A., & Bardo, M. T. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902030243 · Cited by 43
Nonkes, L. J. P., Tomson, K., Märtin, A., Dederen, J., Maes, J. H. R., & Homberg, J. R. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.04.002 · Cited by 42
Self-citationSastre-Coll, A., Esteban, S., & García-Sevilla, J. A. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0508-8 · Cited by 42
Przegaliński, E., Gołda, A., Frankowska, M., Zaniewska, M., & Filip, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.012 · Cited by 42
Quarta, D., Naylor, C., & Stolerman, I. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0802-3 · Cited by 42
Further evidence for the mechanisms that may mediate nicotine discrimination
Schechter, M., & Meehan, S. M. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90231-4 · Cited by 42
Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys
Gold, L. H., & Balster, R. L. (1992) · Psychopharmacology · doi:10.1007/bf02245114 · Cited by 42
VALENTINA, & TEIDER, V. (1996) · Experiment · doi:10.1163/2211730x96x00153 · Cited by 41
Müller, C. P., Silva, M. A. D. S., & Huston, J. P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.002 · Cited by 41
Self-citationConditioned place preference for cocaine is attenuated in mice over-expressing the 5-HT 3 receptor
Allan, A. M., Galindo, R., Chynoweth, J., Engel, S., & Savage, D. D. (2001) · Psychopharmacology · doi:10.1007/s002130100833 · Cited by 41
Müller, C. P., Carey, R. J., Salloum, J. B., & Huston, J. P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00046-7 · Cited by 41
Self-citationHédou, G., Homberg, J. R., Martín, S., Wirth, K., Feldon, J., & Heidbreder, C. A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00038-8 · Cited by 41
Self-citationSmith, J. E., Shultz, K., Co, C., Goeders, N. E., & Dworkin, S. I. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90173-0 · Cited by 41
Cornish, J., Maany, I., Fudala, P. J., Ehrman, R. N., Robbins, S. J., & O'Brien, C. P. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00140-x · Cited by 40
Hayslett, R. L., & Tizabi, Y. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.010 · Cited by 40
Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats
Gulati, A., & Bhargava, H. N. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90284-d · Cited by 40
Activation of serotonin (5-HT)1A receptors inhibits amphetamine sensitization in mice
Przegaliński, E., Siwanowicz, J., Baran, L., & Filip, M. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00666-9 · Cited by 40
Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine
Silverstone, P. H., Oldman, D., Johnson, B., & Cowen, P. J. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199200710-00005 · Cited by 40
Barr, J. L., & Forster, G. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.020 · Cited by 40
Will, M. J., Der-Avakian, A., Bland, S. T., Grahn, R. E., Hammack, S. E., Sparks, P. D., Pepin, J. L., Watkins, L. R., & Maier, S. F. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1572-1 · Cited by 40
Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behavior in rats
Miszkiel, J., & Przegaliński, E. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71062-4 · Cited by 40
Nonkes, L. J. P., de Pooter, M., & Homberg, J. R. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110116 · Cited by 40
Self-citationFluoxetine, smoking, and history of major depression: A randomized controlled trial.
Spring, B. J., Doran, N., Pagoto, S., McChargue, D. E., Cook, J. W., Bailey, K. C., Crayton, J. W., & Hedeker, D. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.1.85 · Cited by 40
Fluoxetine as a Potential Pharmacotherapy for Methamphetamine Dependence
Takamatsu, Y., Yamamoto, H., Ogai, Y., Hagino, Y., Markou, A., & Ikeda, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.026 · Cited by 39
Pum, M. E., Huston, J. P., Silva, M. A. D. S., & Müller, C. P. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.029 · Cited by 39
Self-citationAnneken, J. H., & Gudelsky, G. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.026 · Cited by 39
Comparative behavioral profile of cocaine and norcocaine in rats and monkeys
Bedford, J. A., Borne, R. F., & Wilson, M. C. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90122-7 · Cited by 39
Self-Efficacy Mediates the Effect of Depression on Smoking Susceptibility in Adolescents
Minnix, J. A., Blalock, J. A., Marani, S. K., Prokhorov, A. V., & Cinciripini, P. M. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr061 · Cited by 39
Maurel, S., Schreiber, R., & Vry, J. D. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199807000-00005 · Cited by 39
Rodsiri, R., Spicer, C. H., Green, A. R., Marsden, C. A., & Fone, K. C. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1921-9 · Cited by 39
van den Buuse, M., Ruimschotel, E., Martin, S., Risbrough, V. B., & Halberstadt, A. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.001 · Cited by 39
Stimulus effects of d-Amphetamine II: DA, NE, and 5-HT mechanisms
West, W. B. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00361-l · Cited by 39
Serotonin3 Receptor Antagonism of Alcohol Intake: Effects of Drinking Conditions
McKinzie, D. L., Eha, R. D., Cox, R., Stewart, R. B., Dyr, W., Murphy, J. M., McBride, W. J., Lumeng, L., & Tk, L. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00132-8 · Cited by 39
Carey, R. J., Huston, J. P., & Müller, C. P. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00917-5 · Cited by 38
Self-citationBarros, M., Dempster, E. L., Illott, N., Chabrawi, S. M., Maior, R. S., Tomaz, C. A. B., Silva, M. A. D. S., Huston, J. P., Mill, J. S., & Müller, C. P. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00409.x · Cited by 38
Self-citationFailure of ritanserin to block cocaine cue reactivity in humans
Ehrman, R. N., Robbins, S. J., Cornish, J., Childress, A. R., & O’Brien, C. P. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01278-1 · Cited by 38
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats
Graves, S. M., & Napier, T. C. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-65 · Cited by 38
Role of 5-HT1B receptors in the sensitization to amphetamine in mice
Przegaliński, E., Siwanowicz, J., Nowak, E., Papla, I., & Filip, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01079-2 · Cited by 38
Carey, R. J., DePalma, G., Damianopoulos, E. N., Shanahan, A., Müller, C. P., & Huston, J. P. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.012 · Cited by 38
Self-citationCocaine-induced conditioned place approach in rats: The role of dose and route of administration
Durazzo, T. C., Gauvin, D. V., Goulden, K. L., Briscoe, R. J., & Holloway, F. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90255-0 · Cited by 38
Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys
Schama, K. F., Howell, L. L., & Byrd, L. D. (1997) · Psychopharmacology · doi:10.1007/s002130050316 · Cited by 38
Zavitsanou, K., Wang, H., Dalton, V. S., & Nguyen, V. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.005 · Cited by 38
Seneviratne, C., Franklin, J. F., Beckett, K., Ma, J. Z., Ait‐Daoud, N., Payne, T. J., Johnson, B. A., & Li, M. D. (2013) · Human Genetics · doi:10.1007/s00439-013-1319-y · Cited by 38
Lunden, J. W., & Kirby, L. G. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.071 · Cited by 38
Carey, R. J. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00253-4 · Cited by 38
Patkar, A. A., Berrettini, W. H., Hoehe, M. R., Hill, K. P., Sterling, R. C., Gottheil, E., & Weinstein, S. P. (2001) · Addiction Biology · doi:10.1080/13556210020077064 · Cited by 38
Steed, E., Jones, C. A., & McCreary, A. C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.026 · Cited by 38
Reveron, M. E., Maier, E. Y., & Duvauchelle, C. L. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.10.038 · Cited by 38
Orejarena, M. J., Lanfumey, L., Maldonado, R. J., & Robledo, P. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001215 · Cited by 38
Witkin, J. M., SAVTCHENKO, N. M., Mashkovsky, M. D., Beekman, M., Munzar, P., Ga̧sior, M., Goldberg, S. R., Ungard, J. T., Kim, J., Shippenberg, T. S., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38086-3 · Cited by 38
Acute effect of ethanol on anxiety and 5-HT in the prefrontal cortex of rats
Langen, B., Dietze, S., & Fink, H. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00219-7 · Cited by 38
Nonkes, L. J. P., van de Vondervoort, I. I. G. M., de Leeuw, M. J. C., Wijlaars, L. P., Maes, J. H. R., & Homberg, J. R. (2012) · Learning & Memory · doi:10.1101/lm.025908.112 · Cited by 37
Self-citationNicotine attenuates DOI-induced head-twitch response in mice: implications for tourette syndrome
Tizabi, Y., Russell, L. T., Johnson, M., & Darmani, N. A. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00194-4 · Cited by 37
Sills, T. L., Greenshaw, A. J., Baker, G. B., & Fletcher, P. J. (1999) · Psychopharmacology · doi:10.1007/s002130050852 · Cited by 37
Cox, S. M. L., Benkelfat, C., Dagher, A., Delaney, J. S., Durand, F., Kolivakis, T., Casey, K. F., & Leyton, M. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084178 · Cited by 37
GENETIC STUDY: 5‐HTTLPR polymorphism, mood disorders and MDMA use in a 3‐year follow‐up study
Martín‐Santos, R., Torrens, M., Poudevida, S., Langohr, K., Cuyàs, E., Pacifici, R., Farré, M., Pichini, S., & de la Torre, R. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00180.x · Cited by 37
Franklin, J. M., Mathew, M., & Carrasco, G. A. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.05.039 · Cited by 36
Kitanaka, N., Kitanaka, J., & Takemura, M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.026 · Cited by 36
Szumlinski, K. K., Frys, K. A., & Kalivas, P. W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300473 · Cited by 36
Vaht, M., Merenäkk, L., Mäestu, J., Veidebaum, T., & Harro, J. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3427-8 · Cited by 36
Chaouloff, F., Courvoisier, H., Moisan, M., & Mormède, P. (1999) · Psychopharmacology · doi:10.1007/s002130050841 · Cited by 36
Payer, D. E., Nurmi, E. L., Wilson, S. A., McCracken, J. T., & London, E. D. (2012) · Translational Psychiatry · doi:10.1038/tp.2011.73 · Cited by 36
Bòsari, S., Bussandri, M., Moi, A., Brambilla, F., Mameli, A., Pizzamiglio, M., Donnini, C., Moi, G., Gerra, G., Garofano, L., et al. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0129-8 · Cited by 36
Neurobiological Changes Mediating the Effects of Chronic Fluoxetine on Cocaine Use
Sawyer, E. K., Mun, J.-Y., Nye, J. A., Kimmel, H. L., Voll, R. J., Stehouwer, J. S., Rice, K. C., Goodman, M. M., & Howell, L. L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.29 · Cited by 36
Manvich, D. F., Kimmel, H. L., Cooper, D. A., & Howell, L. L. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195156 · Cited by 36
Glennon, R. A., Higgs, R., Young, R., & Issa, H. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90488-2 · Cited by 35
The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus
Mansbach, R. S., Rovetti, C. C., & Freedland, C. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00085-4 · Cited by 35
Rüedi‐Bettschen, D., Rowlett, J. K., Spealman, R. D., & Platt, D. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1705-2 · Cited by 35
Batman, A. M., Munzar, P., & Beardsley, P. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2035-z · Cited by 35
Different Phenotypic and Genotypic Presentations in Alcohol Dependence: Age at Onset Matters
Chen, Y.-C., Prescott, C. A., Walsh, D., Patterson, D. G., Riley, B. P., Kendler, K. S., & Kuo, P. (2011) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2011.72.752 · Cited by 35
Rozeske, R. R., Greenwood, B. N., Fleshner, M., Watkins, L. R., & Maier, S. F. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.030 · Cited by 35
A Candidate Gene Association Study of Alcohol Consumption in Young Women*
Arpana Agrawal, A., Lynskey, M. T., Todorov, A. A., Schrage, A. J., Littlefield, A. K., Grant, J. D., Zhu, Q., Nelson, E. C., Madden, P. A. F., Bucholz, K. K., et al. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01372.x · Cited by 34
The 5-HT4 receptor antagonist, GR113808, reduces ethanol intake in alcohol-preferring rats
Panocka, I., Ciccocioppo, R., Polidori, C., et al. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00078-b · Cited by 34
Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion
Layer, R. T., Uretsky, N. J., & Wallace, L. J. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90187-t · Cited by 34
Gilbert, D. G., Zuo, Y., Rabinovich, N. E., Riise, H., Needham, R., & Huggenvik, J. I. (2009) · Journal of Abnormal Psychology · doi:10.1037/a0015382 · Cited by 34
Effects of ondansetron administration on opioid withdrawal syndrome observed in rats
Pinelli, A., Trivulzio, S., & TOMASONI, L. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01349-6 · Cited by 34
Gartside, S. E., McQuade, R., & Sharp, T. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00171-8 · Cited by 34
Xiong, W., Koo, B.-N., Morton, R., & Zhang, L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.066 · Cited by 34
Watanabe, Y., Yoshimoto, K., Tatebe, H., Kita, M., Nishikura, K., Kimura, M., & Tanaka, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001545 · Cited by 34
Kranzler, H. R., Scott, D. M., Tennen, H. A., Feinn, R., Williams, C. D., Armeli, S., Taylor, R. E., Briggs‐Gowan, M. J., & Covault, J. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32051 · Cited by 34
The effects of SB 224289 on anxiety and cocaine-related behaviors in a novel object task
Hoplight, B. J., Vincow, E. S., & Neumaier, J. F. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.02.016 · Cited by 33
Drug-induced place preference in rats with 5,7-dihydroxytryptamine lesions of the nucleus accumbens
Spyraki, C., Nomikos, G. G., Galanopoulou, P., & Daïfotis, Z. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90060-5 · Cited by 33
Grady, T. A., Broocks, A., Canter, S. K., Pigott, T. A., Dubbert, B. K., Hill, J., & Murphy, D. L. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02884-3 · Cited by 33
The serotonin transporter gene polymorphism is not associated with smoking behavior
Trummer, O., Köppel, H., Wascher, T. C., Grünbacher, G., Gutjahr, M., Stanger, O., Ramschak-Schwarzer, S., Boehm, B. O., Winkelmann, B. R., März, W., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500389 · Cited by 33
Noèlia Fernàndez-castillo, A., Roncero, C., Grau‐López, L., Barral, C., Prat, G., Rodríguez-Cintas, L., Sánchez‐Mora, C., Gratacòs, M., Ramos‐Quiroga, J. A., Casas, M., et al. (2012) · Genes Brain & Behavior · doi:10.1111/gbb.12013 · Cited by 33
Ettenberg, A., & Bernardi, R. E. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.014 · Cited by 33
Global Ethanol-Induced Enhancements of Monoaminergic Neurotransmission: A Meta-Analysis Study
Brand, I., Fliegel, S., Spanagel, R., & Noori, H. R. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12207 · Cited by 32
Li, J., Shah, A. P., Patel, S. K., Rice, K. C., & France, C. P. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2870-2 · Cited by 32
Patkar, A. A., Berrettini, W. H., Mannelli, P., Gopalakrishnan, R., Hoehe, M. R., Bilal, L., Weinstein, S. P., & Vergare, M. J. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200403000-00004 · Cited by 32
Sills, T. L., Greenshaw, A., Baker, G. B., & Fletcher, P. (1999) · Psychopharmacology · doi:10.1007/s002130050968 · Cited by 32
Murnane, K. S., Andersen, M. L., Rice, K. C., & Howell, L. L. (2013) · Journal of Sleep Research · doi:10.1111/jsr.12045 · Cited by 32
Filip, M., Spampinato, U., McCreary, A. C., & Przegaliński, E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.035 · Cited by 32
The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density
Yang, K. H. S., Isaev, D. S., Morales, M., Petroianu, G. A., Galadari, S., & Öz, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.044 · Cited by 31
Pum, M. E., Carey, R. J., Huston, J. P., & Müller, C. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1296-3 · Cited by 31
Self-citationDing, Z., Toalston, J. E., Oster, S. M., McBride, W. J., & Rodd, Z. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1468-9 · Cited by 31
Suzuki, T., Ise, Y., Mori, T., & Misawa, M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00745-5 · Cited by 31
Association of MAO A polymorphism and alcoholism in Brazilian females
Guindalini, C., Scivoletto, S., Ferreira, R. D. G. M., Nishimura, A. L., Zilberman, M. L., Peluso, M. A. M., & Zatz, M. (2005) · Psychiatric Genetics · doi:10.1097/00041444-200506000-00011 · Cited by 31
Czoty, P. W., McCabe, C., & Nader, M. A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200505000-00008 · Cited by 31
Thielen, R. J., Bare, D. J., McBride, W. J., Lumeng, L., & Li, T. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00633-5 · Cited by 31
Nicotinic modulation of serotonergic activity in the dorsal raphe nucleus
Hernández‐López, S., Garduño, J., & Mihailescu, S. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0012 · Cited by 31
Zaniewska, M., McCreary, A. C., Wydra, K., & Filip, M. (2010) · Synapse · doi:10.1002/syn.20756 · Cited by 31
Gillies, D. M., Mylecharane, E. J., & Jackson, D. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00028-3 · Cited by 31
Olausson, P., Åkesson, P., Petersson, A., Engel, J. A., & Söderpalm, B. (2001) · Psychopharmacology · doi:10.1007/s002130100710 · Cited by 31
The serotonin 2A receptor gene in alcohol dependence and tobacco smoking
Polina, E. R., Contini, V., Hutz, M. H., & Bau, C. H. D. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.001 · Cited by 31
Sperling, R. E., & Commons, K. G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07677.x · Cited by 31
Chu, S., Xiao, D., Wang, C., & Jing, H. (2009) · PubMed · Cited by 30
Depression vulnerability, cigarette smoking, and the serotonin transporter gene
Brody, C., Hamer, D. H., & Haaga, D. A. F. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.08.005 · Cited by 30
Markou, A., Harrison, A. A., Chevrette, J., & Hoyer, D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2008-2 · Cited by 30
Yang, Z.-L., Seneviratne, C., Wang, S.-L., Ma, J.-N. Z., Payne, T., Wang, J.-D., & Li, M. D. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.007 · Cited by 30
Yasuda, K., Suemaru, K., Araki, H., & Gomita, Y. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0592-4 · Cited by 30
Tan, E., Yeo, B., Ho, B. K. W., Tay, A. H. N., & Tan, C. H. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000541 · Cited by 30
Flórez, G., Sáiz, P. A., García‐Portilla, M. P., Álvarez, S., Nogueiras, L., Morales, B., Álvarez, V., Coto, E., & Bobes, J. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn048 · Cited by 29
Mello, N. K., Fivel, P. A., & Kohut, S. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.25 · Cited by 29
Paulus, M. P., Callaway, C. W., & Geyer, M. A. (1993) · Psychopharmacology · doi:10.1007/bf02245696 · Cited by 29
Sachs, B. D., Salahi, A. A., & Caron, M. G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.010 · Cited by 29
Craige, C. P., & Unterwald, E. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.034 · Cited by 29
Marques, F. Z., Hutz, M. H., & Bau, C. H. D. (2006) · Psychiatric Genetics · doi:10.1097/01.ypg.0000199449.07786.7d · Cited by 29
5‐HT3 antagonists reduce morphine self‐administration in rats
Hui, S. G., Sevilla, E. L., & Ogle, C. W. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13966.x · Cited by 29
Mosner, A., Kuhlman, G., Roehm, C., et al. (2008) · Pharmacology · doi:10.1159/000139486 · Cited by 29
Fletcher, P. J., Sinyard, J., Salsali, M., & Baker, G. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1747-9 · Cited by 29
Liang, Y., Boules, M., Shaw, A. M., Williams, K., Fredrickson, P. A., & Richelson, E. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.037 · Cited by 29
Baumann, M. H., Williams, Z. R., Żółkowska, D., & Rothman, R. B. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.09.015 · Cited by 29
David, S. P., Johnstone, E. C., Murphy, M. F., Aveyard, P. N., Guo, B., Lerman, C. E., & Munafo, M. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.04.013 · Cited by 29
Staub, D. R., Lunden, J. W., Cathel, A. M., Dolben, E. L., & Kirby, L. G. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.10.002 · Cited by 29
Munzar, P., Justinová, Z., Kutkat, S. W., & Goldberg, S. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01598-9 · Cited by 29
Lutz, P.-É., Pradhan, A. A. A., Goeldner, C., & Kieffer, B. L. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.02.002 · Cited by 28
Effects of ethanol on the dorsal raphe nucleus and its projections to the caudate putamen
Thielen, R. J., Morzorati, S. L., & McBride, W. J. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00126-4 · Cited by 28
Parallel changes in serotonin levels in brain and blood following acute administration of MDMA
Collins, C. M., Kloek, J., & Elliott, J. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112463123 · Cited by 28
Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors
Salomon, L., Lanteri, C., Godeheu, G., Blanc, G., Gingrich, J. A., & Tassin, J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0810-3 · Cited by 28
Ma, Z., Strecker, R. E., McKenna, J. T., Thakkar, M. M., McCarley, R. W., & Tao, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.074 · Cited by 28
Rutter, J. J., Baumann, M. H., & Waterhouse, B. D. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00320-5 · Cited by 28
Semba, J., & Wakuta, M. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01822.x · Cited by 28
5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats
Arnold, B. D. C., Allison, K., Ivanova, S. А., Paetsch, P. R., Paslawski, T., & Greenshaw, A. J. (1995) · Psychopharmacology · doi:10.1007/bf02246163 · Cited by 28
Perret, G., Schluger, J. H., Unterwald, E. M., Kreuter, J., Ho, A., & Kreek, M. J. (1998) · Synapse · Cited by 28
Francis, H., Kraushaar, N., Hunt, L. R., & Cornish, J. L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1982-9 · Cited by 28
Filip, M., Papla, I., Nowak, E., Czepiel, K., & Przegaliński, E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02873-x · Cited by 28
Davidson, C., Gopalan, R., Ahn, C., Chen, Q., Mannelli, P., Patkar, A. A., Weese, G. D., Lee, T. H., & Ellinwood, E. H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.056 · Cited by 28
GENETIC STUDY: Tryptophan hydroxylase 2 gene and alcohol use among college students
Gacek, P., Conner, T. S., Tennen, H. A., Kranzler, H. R., & Covault, J. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00118.x · Cited by 28
Cosgrove, K., Tellez-Jacques, K., Pittman, B. P., Petrakis, I. L., Baldwin, R. M., Tamagnan, G. D., Seibyl, J. P., Kosten, T. R., & Staley, J. K. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.08.001 · Cited by 28
Depletion of brain serotonin following intra-raphe injections
Fletcher, P. J., Korth, K. M., & Chambers, J. W. (1999) · Psychopharmacology · doi:10.1007/s002130051105 · Cited by 28
Ettenberg, A., Ofer, O. A., Mueller, C. L., Waldroup, S. A., Cohen, A., & Ben‐Shahar, O. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.008 · Cited by 27
Maj, J., Rogóż, Z., Skuza, G., & Wędzony, K. (1996) · Journal of Neural Transmission · doi:10.1007/bf01292622 · Cited by 27
Gould, R. W., Gage, H. D., Banks, M. L., Blaylock, B. L., Czoty, P. W., & Nader, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.007 · Cited by 27
Herges, S., & TAYLOR, D. A. H. B. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900058 · Cited by 27
5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat
Reavill, C., Hatcher, J. P., Lewis, V. A., Sanger, G. J., & Hagan, J. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00564-0 · Cited by 27
Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression
Kassai, F., Schlumberger, C., Kedves, R., Pietraszek, M., Jatzke, C., Lendvai, B., Gyertyán, I., & Danysz, W. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283565248 · Cited by 27
MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain
Perrine, S. A., Ghoddoussi, F., Michaels, M. S., Hyde, E. M., Kuhn, D. M., & Galloway, M. P. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.08.005 · Cited by 27
Pockros, L. A., Pentkowski, N. S., Conway, S. M., Ullman, T. E., Zwick, K. R., & Neisewander, J. L. (2012) · Synapse · doi:10.1002/syn.21592 · Cited by 27
Mannelli, P., Patkar, A. A., Murray, H. W., Certa, K., Peindl, K., Mattila‐Evenden, M., & Berrettini, W. H. (2005) · Addiction Biology · doi:10.1080/13556210500235540 · Cited by 27
The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome:
Gray, A. M. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00028-7 · Cited by 26
Filip, M., Nowak, E., Papla, I., & Przegaliński, E. (2001) · PubMed · Cited by 26
White, M. J., Young, R. M., Morris, C. P., & Lawford, B. R. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.08.014 · Cited by 26
Suemaru, K., Araki, H., Kitamura, Y., et al. (2001) · Psychopharmacology · doi:10.1007/s002130100866 · Cited by 26
Cao, J.-X., Hu, J., Ye, X., Xia, Y., Haile, C. N., Kosten, T. R., & Zhang, X. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.039 · Cited by 26
Takamatsu, Y., Yamamoto, H., Hagino, Y., Markou, A., & Ikeda, K. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017236 · Cited by 26
A haplotype analysis is consistent with the role of functional HTR1B variants in alcohol dependence
Contini, V., Bertuzzi, G. P., Polina, E. R., et al. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.020 · Cited by 26
Intracellular 5-HT2C-receptor dephosphorylation: a new target for treating drug addiction
Müller, C. P., & Carey, R. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.003 · Cited by 26
Self-citation
Research works printed but not linked: 97
- Abdollahian, 2006, Study of the efficacy of fluoxetine and clomipramine in the treatment of premature ejaculation after opioid detoxification, Am J Addict, 15, 100, 10.1080/10550490500419151 · doi:10.1080/10550490500419151
- Acquas, 1988, 5-HT3 receptors antagonists block morphine- and nicotine- but not amphetamine-induced place-preference conditioning, Pharmacol Res Commun, 20, 1113, 10.1016/S0031-6989(88)80752-5 · doi:10.1016/s0031-6989(88)80752-5
- Adell, 1995, Selective destruction of midbrain raphe nuclei by 5,7-DHT: is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats?, Brain Res, 693, 70, 10.1016/0006-8993(95)00701-Q · doi:10.1016/0006-8993(95)00701-q
- Ali, 1996, 8-OH-DPAT enhances the expression of cocaine-induced place preference, Br J Pharmacol Suppl, 119, 207P
- Baker, 1993, The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds, Behav Pharmacol, 4, 69, 10.1097/00008877-199302000-00008 · doi:10.1097/00008877-199302000-00008
- Baker, 1997, Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA), Pharmacol Biochem Behav, 58, 505, 10.1016/S0091-3057(97)00287-6 · doi:10.1016/s0091-3057(97)00287-6
- Bare, 1998, Development of rapid tolerance to ethanol-stimulated serotonin release in the ventral hippocampus, Alcohol Clin Exp Res, 22, 1272, 10.1111/j.1530-0277.1998.tb03908.x · doi:10.1111/j.1530-0277.1998.tb03908.x
- Berthold, 1989, 5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice, Eur J Pharmacol, 162, 19, 10.1016/0014-2999(89)90599-2 · doi:10.1016/0014-2999(89)90599-2
- Bilsky, 1991, MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference, Pharmacol Biochem Behav, 39, 509, 10.1016/0091-3057(91)90217-P · doi:10.1016/0091-3057(91)90217-p
- Bisaga, 1993, The effect of drugs interacting with serotonergic 5-HT3 and 5-HT4 receptors on morphine place conditioning, Pol J Pharmacol, 45, 513
- Bronsert, 2001, Amphetamine-induced locomotor activation in 5-HT(1B) knockout mice: effects of injection route on acute and sensitized responses, Behav Pharmacol, 12, 549, 10.1097/00008877-200111000-00017 · doi:10.1097/00008877-200111000-00017
- Burnett, 2012, The effects of chronic ethanol self-administration on hippocampal serotonin transporter density in monkeys, Front Psychiatry, 3, 38, 10.3389/fpsyt.2012.00038 · doi:10.3389/fpsyt.2012.00038
- Callahan, 1997, Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists, Neuropharmacology, 36, 373, 10.1016/S0028-3908(97)00010-5 · doi:10.1016/s0028-3908(97)00010-5
- Carey, 2002, 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms, Behav Brain Res, 132, 37, 10.1016/S0166-4328(01)00383-7 · doi:10.1016/s0166-4328(01)00383-7
- Carey, 2005, Pharmacological inhibition of DA- and 5-HT activity blocks spontaneous and cocaine-activated behavior: reversal by chronic cocaine treatment, Brain Research, 1047, 194, 10.1016/j.brainres.2005.04.042 · DOI
- Cervo, 1996, 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats, Pharmacol Biochem Behav, 55, 33, 10.1016/0091-3057(96)00046-9 · doi:10.1016/0091-3057(96)00046-9
- Ciccocioppo, 1997, Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats, Psychopharmacology (Berl), 134, 55, 10.1007/s002130050425 · doi:10.1007/s002130050425
- Conductier, 2005, 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221, Neuropsychopharmacology, 30, 1056, 10.1038/sj.npp.1300662 · doi:10.1038/sj.npp.1300662
- De La Garza, 1996, Detailed investigations of 5-HT3 compounds in a drug discrimination model, Pharmacol Biochem Behav, 54, 533, 10.1016/0091-3057(95)02207-4 · doi:10.1016/0091-3057(95)02207-4
- De La Garza, 1998, The discriminative stimulus properties of cocaine: effects of microinfusion of cocaine, a 5-HT1A agonist or antagonist, into the ventral tegmental area, Psychopharmacology (Berl), 137, 1, 10.1007/s002130050586 · doi:10.1007/s002130050586
- Devoto, 1998, Serotonin is reduced in the frontal cortex of Sardinian ethanol-preferring rats, Alcohol Alcohol, 33, 226, 10.1093/oxfordjournals.alcalc.a008386 · DOI
- Dukat, 2007, The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats, Pharmacol Biochem Behav, 87, 203, 10.1016/j.pbb.2007.03.008 · doi:10.1016/j.pbb.2007.03.008
- El-Kadi, 1995, The role of 5-Ht in the expression of morphine-withdrawal in mice, Life Sci, 57, 511, 10.1016/0024-3205(95)00284-D · doi:10.1016/0024-3205(95)00284-d
- Filip, 2001, Serotonin1B receptor ligands in the nucleus accumbens shell do not affect the discriminative stimulus effects of amphetamine in rats, Pol J Pharmacol, 53, 449
- Filip, 2002, Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats, Naunyn Schmiedebergs Arch Pharmacol, 366, 226, 10.1007/s00210-002-0583-5 · doi:10.1007/s00210-002-0583-5
- Filip, 2006, Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats, Psychopharmacology (Berl), 183, 482, 10.1007/s00213-005-0197-y · doi:10.1007/s00213-005-0197-y
- Fletcher, 1999, RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors, Behav Pharmacol, 10, 183, 10.1097/00008877-199903000-00007 · doi:10.1097/00008877-199903000-00007
- Frankel, 2004, m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor, Behav Neurosci, 118, 157, 10.1037/0735-7044.118.1.157 · doi:10.1037/0735-7044.118.1.157
- George, 1997, Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects, Am J Psychiatry, 154, 81, 10.1176/ajp.154.1.81 · doi:10.1176/ajp.154.1.81
- Glennon, 2000, MDMA stimulus generalization to the 5-HT1A serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin, Pharmacol Biochem Behav, 66, 483, 10.1016/S0091-3057(00)00174-X · doi:10.1016/s0091-3057(00)00174-x
- Grauer, 1992, Morphine induces an increase in extracellular serotonin in the rat diencephalon, Brain Res, 599, 277, 10.1016/0006-8993(92)90402-U · doi:10.1016/0006-8993(92)90402-u
- Gulati, 1988, Cerebral cortical 5-Ht1 and 5-Ht2 receptors of morphine tolerant-dependent rats, Neuropharmacology, 27, 1231, 10.1016/0028-3908(88)90025-1 · doi:10.1016/0028-3908(88)90025-1
- Gulati, 1989, Brain and spinal-cord 5-Ht2 receptors of morphine-tolerant-dependent and morphine-abstinent rats, Eur J Pharmacol, 167, 185, 10.1016/0014-2999(89)90578-5 · doi:10.1016/0014-2999(89)90578-5
- Higgins, 1992, Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system, Neurosci Biobehav Rev, 16, 535, 10.1016/S0149-7634(05)80195-2 · doi:10.1016/s0149-7634(05)80195-2
- Higgins, 1993, Preliminary findings with the indirect 5-Ht agonist dexfenfluramine on heroin discrimination and self-administration in rats, Pharmacol Biochem Behav, 45, 963, 10.1016/0091-3057(93)90148-M · doi:10.1016/0091-3057(93)90148-m
- Ikeda, 2011, Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain, Eur J Pharmacol, 660, 318, 10.1016/j.ejphar.2011.03.050 · doi:10.1016/j.ejphar.2011.03.050
- Ivanova, 2002, Effect of monoamine oxidase A knockout on resistance to long-term exposure to ethanol, Bull Exp Biol Med, 133, 603, 10.1023/A:1020254430169 · doi:10.1023/a:1020254430169
- Javaid, 1993, Repeated cocaine administration does not affect 5-Ht receptor subtypes (5-Ht(1A), 5-Ht2) in several rat-brain regions, Eur J Pharmacol, 238, 425, 10.1016/0014-2999(93)90880-Q · doi:10.1016/0014-2999(93)90880-q
- Johnson, 1993, Effects of chronic cocaine administration on the serotonergic system in the rat-brain, Pharmacol Bioch Behav, 46, 289, 10.1016/0091-3057(93)90355-W · doi:10.1016/0091-3057(93)90355-w
- Kenna, 2010, Medications acting on the serotonergic system for the treatment of alcohol dependent patients, Curr Pharm Des, 16, 2126, 10.2174/138161210791516396 · doi:10.2174/138161210791516396
- King, 1993, Withdrawal from continuous or intermittent cocaine – effects of Nan-190 on cocaine-induced locomotion, Pharmacol Biochem Behav, 44, 253, 10.1016/0091-3057(93)90459-7 · doi:10.1016/0091-3057(93)90459-7
- King, 1994, 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine, Pharmacol Biochem Behav, 47, 399, 10.1016/0091-3057(94)90135-X · doi:10.1016/0091-3057(94)90135-x
- Koetzner, 1995, Facilitating role of m-chlorophenylbiguanide in a cocaine discrimination, Pharmacol Biochem Behav, 52, 815, 10.1016/0091-3057(95)00176-W · doi:10.1016/0091-3057(95)00176-w
- Kotler, 1999, No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (Ball D2DR) polymorphisms and heroin addiction, Mol Psychiatry, 4, 313, 10.1038/sj.mp.4000499 · doi:10.1038/sj.mp.4000499
- Lamb, 2014, Ethanol effects on multiple fixed-interval, fixed-ratio responding in mice with deletions of the serotonin transporter gene, Behav Pharmacol, 25, 92, 10.1097/FBP.0000000000000011 · doi:10.1097/fbp.0000000000000011
- Landabaso, 1998, A randomized trial of adding fluoxetine to a naltrexone treatment programm for heroin addicts, Addiction, 93, 739, 10.1046/j.1360-0443.1998.9357399.x · doi:10.1046/j.1360-0443.1998.9357399.x
- Lehmann, 2000, When injected into the fimbria-fornix/cingular bundle, not in the raphe, 5,7-dihydroxytryptamine prevents amphetamine-induced hyperlocomotion, Behav Brain Res, 114, 213, 10.1016/S0166-4328(00)00246-1 · doi:10.1016/s0166-4328(00)00246-1
- Li, 2011, Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys, Neuropsychopharmacology, 36, 940, 10.1038/npp.2010.232 · doi:10.1038/npp.2010.232
- Li, 2002, Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects, Am J Med Genet, 114, 329, 10.1002/ajmg.10200 · DOI
- Liu, 2006, Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity, Drug Alcohol Depend, 81, 275, 10.1016/j.drugalcdep.2005.07.007 · doi:10.1016/j.drugalcdep.2005.07.007
- Lovinger, 2000, Ethanol and trichloroethanol alter gating of 5-HT3 receptor-channels in NCB-20 neuroblastoma cells, Neuropharmacology, 39, 561, 10.1016/S0028-3908(99)00164-1 · doi:10.1016/s0028-3908(99)00164-1
- Lu, 1993, Ethanol consumption following acute fenfluramine, fluoxetine, and dietary tryptophan, Pharmacol Biochem Behav, 44, 931, 10.1016/0091-3057(93)90027-Q · doi:10.1016/0091-3057(93)90027-q
- Lu, 1994, Ethanol consumption following acute treatment with methysergide, fluoxetine, fenfluramine, and their combination, Alcohol Clin Exp Res, 18, 60, 10.1111/j.1530-0277.1994.tb00881.x · doi:10.1111/j.1530-0277.1994.tb00881.x
- Maurel, 1997, Substitution of the selective serotonin reuptake inhibitors fluoxetine and paroxetine for the discriminative stimulus effects of ethanol in rats, Psychopharmacology (Berl), 130, 404, 10.1007/s002130050257 · doi:10.1007/s002130050257
- Maurel, 1999, Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats, Alcohol, 17, 195, 10.1016/S0741-8329(98)00046-9 · doi:10.1016/s0741-8329(98)00046-9
- Maurel, 1999, 5-HT2A and 5-HT2C/5-HT1B receptors are differentially involved in alcohol preference and consummatory behavior in cAA rats, Pharmacol Biochem Behav, 62, 89, 10.1016/S0091-3057(98)00115-4 · doi:10.1016/s0091-3057(98)00115-4
- McCorvy, 2011, A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference, Neurosci Lett, 505, 10, 10.1016/j.neulet.2011.07.036 · doi:10.1016/j.neulet.2011.07.036
- McMahon, 1999, Antagonism of 5-hydroxytryptamine(4) receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine(4) receptors in the nucleus accumbens shell, J Pharmacol Exp Ther, 291, 300, 10.1016/S0022-3565(24)35101-8 · DOI
- Millan, 1998, J Pharmacol Exp Ther, 286, 1356, 10.1016/S0022-3565(24)37732-8 · doi:10.1016/s0022-3565(24)37732-8
- Miranda, 2007, Modulatory role of 5-HT1B receptors in the discriminative signal of amphetamine in the conditioned taste aversion paradigm, Pharmacol Rep, 59, 517
- Molina, 2001, l-Tryptophan attenuation of the dopaminergic and behavioral responses to cocaine, Life Sci, 69, 1897, 10.1016/S0024-3205(01)01276-0 · doi:10.1016/s0024-3205(01)01276-0
- Moser, 1992, The effect of 5-HT3 receptor antagonists on the discriminative stimulus effects of amphetamine, Eur J Pharmacol, 212, 271, 10.1016/0014-2999(92)90342-2 · doi:10.1016/0014-2999(92)90342-2
- Müller, 2004, Nucleus accumbens serotonin1A receptors control cocaine-induced hyperactivity but not local serotonin increase: an in vivo microdialysis study, Neuropharmacology, 47, 205, 10.1016/j.neuropharm.2004.03.020 · DOI
- Munn, 2002, Increases in the release and metabolism of serotonin in nucleus parafascicularis thalami following systemically administered morphine in the rat, Neurosci Lett, 332, 151, 10.1016/S0304-3940(02)00949-7 · doi:10.1016/s0304-3940(02)00949-7
- Nader, 1994, Blockade of the discriminative stimulus effects of d-amphetamine in rhesus-monkeys with serotonin 5-Ht1A agonists, Behav Pharmacol, 5, 591, 10.1097/00008877-199410000-00004 · doi:10.1097/00008877-199410000-00004
- Nakamura, 2006, Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonst in mice, Synapse, 60, 479, 10.1002/syn.20323 · doi:10.1002/syn.20323
- Paris, 1991, Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine, Psychopharmacology (Berl), 104, 475, 10.1007/BF02245652 · doi:10.1007/bf02245652
- Platt, 1999, Discriminative stimulus effects of morphine in squirrel monkeys: Stimulants, opioids, and stimulant-opioid combinations, J Pharmacol Exp Ther, 290, 1092, 10.1016/S0022-3565(24)35010-4 · DOI
- Powell, 1994, Serotonin Involvement in the discriminative stimulus effects of mu-opioids and kappa-opioids in rats, Behav Pharmacol, 5, 255
- Przegalinski, 2002, Effects of 5-HT1B receptor ligands microinjected into the accumbal shell or core on the cocaine-induced locomotor hyperactivity in rats, J Physiol Pharmacol, 53, 383
- Przegalinski, 2003, Withdrawal from chronic cocaine up-regulates 5-HT1B receptors in the rat brain, Neurosci Lett, 351, 169, 10.1016/j.neulet.2003.08.007 · doi:10.1016/j.neulet.2003.08.007
- Przegalinski, 2004, Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats, Eur Neuropsychopharmacol, 14, 217, 10.1016/S0924-977X(03)00106-8 · doi:10.1016/s0924-977x(03)00106-8
- Pullagurla, 2004, Modulation of the stimulus effects of (+)amphetamine by the 5-HT6 antagonist MS-245, Pharmacol Biochem Behav, 78, 263, 10.1016/j.pbb.2004.03.017 · doi:10.1016/j.pbb.2004.03.017
- Rapoza, 1993, Buspirone fails to affect the discriminative stimulus effects of cocaine, Pharmacol Biochem Behav, 45, 179, 10.1016/0091-3057(93)90102-Y · doi:10.1016/0091-3057(93)90102-y
- Reith, 1990, 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice, Eur J Pharmacol, 186, 327, 10.1016/0014-2999(90)90454-E · doi:10.1016/0014-2999(90)90454-e
- Rezvani, 1994, Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction, Pharmacol Biochem Behav, 48, 105, 10.1016/0091-3057(94)90505-3 · doi:10.1016/0091-3057(94)90505-3
- Rodd-Henricks, 2000, Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats, Alcohol, 21, 73, 10.1016/S0741-8329(00)00083-5 · doi:10.1016/s0741-8329(00)00083-5
- Rowland, 1992, Effect of dexfenfluramine on alcohol intake in alcohol-preferring “P” rats, Alcohol, 9, 559, 10.1016/0741-8329(92)90097-T · doi:10.1016/0741-8329(92)90097-t
- Roychoudhury, 1996, Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist, Meth Find Exp Clin Pharmacol, 18, 677
- Schechter, 1972, Nicotine as a discriminative stimulus in rats depleted of norepinephrine or 5-hydroxytryptamine, Psychopharmacologia, 24, 417, 10.1007/BF00402536 · doi:10.1007/bf00402536
- Sershen, 1996, Effect of ibogaine on cocaine-induced efflux of [3H] dopamine and [3H] serotonin from mouse striatum, Pharmacol Biochem Behav, 53, 863, 10.1016/0091-3057(95)02098-5 · doi:10.1016/0091-3057(95)02098-5
- Sills, 1997, Fluoxetine attenuated morphine-induced locomotion and blocks morphine-sensitization, Eur J Pharmacol, 337, 161, 10.1016/S0014-2999(97)01308-3 · doi:10.1016/s0014-2999(97)01308-3
- Soto, 2009, Citalopram enhances cocaine's subjective effects in rats, Behav Pharmacol, 20, 759, 10.1097/FBP.0b013e328333a267 · doi:10.1097/fbp.0b013e328333a267
- Spealman, 1993, Modification of behavioral-effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel-monkeys, Psychopharmacology, 112, 93, 10.1007/BF02247368 · doi:10.1007/bf02247368
- Sprouse, 1989, Mdma (3,4-Methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain-slices via release of serotonin, Eur J Pharmacol, 167, 375, 10.1016/0014-2999(89)90446-9 · doi:10.1016/0014-2999(89)90446-9
- Starr, 2012, Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus, J Pharmacol Exp Ther, 340, 73, 10.1124/jpet.111.185728 · doi:10.1124/jpet.111.185728
- Sudakov, 2007, Self-administration of morphine by rats causes monoamine release in the anterior cingulate cortex, Bull Exp Biol Med, 144, 210, 10.1007/s10517-007-0291-8 · doi:10.1007/s10517-007-0291-8
- Suzuki, 1992, 5-HT3 receptor antagonists block cocaine- and methamphetamine-induced place preference, Yakubutsu Seishin Kodo, 12, 33
- Tristan-Noguero, 2013, Lack of association between the LPR and VNTR polymorphisms of the serotonin transporter gene and cocaine dependence in a Spanish sample, Psychiatry Res, 210, 1287, 10.1016/j.psychres.2013.09.004 · doi:10.1016/j.psychres.2013.09.004
- Wang, 1995, Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration, Psychopharmacology, 120, 134, 10.1007/BF02246185 · doi:10.1007/bf02246185
- Wilson, 1996, The 5-HT1A receptor agonist 8-OH-DPAT reduces ethanol intake and maintained behavior in female Sprague-Dawley rats, Alcohol, 13, 407, 10.1016/0741-8329(95)02110-8 · doi:10.1016/0741-8329(95)02110-8
- Winter, 1977, Morphine and ethanol as discriminative stimuli – absence of antagonism by para-chlorophenylalanine methyl-ester, cinanserin, or Bc-105, Psychopharmacology, 53, 159, 10.1007/BF00426486 · doi:10.1007/bf00426486
- Wrzosek, 2012, Serotonin 2A receptor gene (HTR2A) polymorphism in alcohol-dependent patients, Pharmacol Rep, 64, 449, 10.1016/S1734-1140(12)70787-9 · doi:10.1016/s1734-1140(12)70787-9
- Yeh, 1991, Cocaine-induced locomotor-activity in rats, Pharmacol Biochem Behav, 39, 723, 10.1016/0091-3057(91)90154-T · doi:10.1016/0091-3057(91)90154-t
- Young, 2006, Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT), Pharmacol Biochem Behav, 83, 612, 10.1016/j.pbb.2006.03.025 · doi:10.1016/j.pbb.2006.03.025
- Yubero-Lahoz, 2012, Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain, Eur J Pharmacol, 674, 337, 10.1016/j.ejphar.2011.10.033 · doi:10.1016/j.ejphar.2011.10.033
- Zhou, 1994, Reduced serotonergic immunoreactive fibers in the forebrain of alcohol-preferring rats, Alcohol Clin Exp Res, 18, 571, 10.1111/j.1530-0277.1994.tb00912.x · DOI
Cited by
The Roles of Serotonin in Neuropsychiatric Disorders
Pourhamzeh, M., Moravej, F. G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R., Ahadi, R., & Joghataei, M. T. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01064-9 · Cited by 366
Adolescent Alcohol Exposure Persistently Impacts Adult Neurobiology and Behavior
Crews, F. T., Vetreno, R. P., Broadwater, M. A., & Robinson, D. L. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012138 · Cited by 324
Neuroscience of Addiction: Relevance to Prevention and Treatment
Volkow, N. D., & Boyle, M. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101174 · Cited by 322
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Lipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Self-citation
Metadata
- Authors
- Müller, C. P., & Homberg, J. R.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 277
- Pages
- 146-192
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2080867289
- Cited by
- 334
- References
- 706
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Friedrich-Alexander-University of Erlangen-Nuremberg
- Dutch Organisation for Scientific Research (40-00812-98-11002, 60-60600-97-354)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.